Medicine Grand Rounds: Chronic Lymphocytic Leukemia in 2023

Dr. Danielle M. Brander, Assistant Professor of Medicine, Hematologic Malignancies and Cellular Therapy, Duke Department of Medicine, will present "Chronic Lymphocytic Leukemia in 2023"

Learning Objectives:
-Understand the heterogeneity of CLL/SLL in diagnosis, disease course, and treatment outcomes, and the factors that contribute to high risk CLL/SLL
-Contrast available treatment options for patients in the frontline and relapsed setting
-Recognize common toxicities of BTK inhibitors and venetoclax and describe strategies to mitigate and manage these side effects
-Identify remaining areas of unmet need for patients with CLL/SLL and Richter's Transformation